前列腺癌早筛是关键 专家：把握50-75岁黄金窗口期

Core Insights - The incidence of prostate cancer in China is rapidly increasing, posing a significant threat to men's health [1] - Early detection through scientific screening and standardized treatment can lead to long-term high-quality survival for patients [1][2] Group 1: Screening and Diagnosis - Prostate cancer early symptoms are often subtle and similar to benign conditions, making standardized screening crucial [1] - PSA (Prostate-Specific Antigen) testing is currently the most effective screening method [1] - The optimal screening age is between 50 to 75 years, with those having a family history advised to start screening at 45 [1] Group 2: Treatment Advances - Recent advancements in treatment methods for prostate cancer have significantly improved patient outcomes [1] - New endocrine therapy drugs have extended the median overall survival for metastatic hormone-sensitive prostate cancer patients to over 8 years, surpassing traditional medications [1] - The application of targeted and radionuclide therapies further benefits survival for late-stage patients [1] Group 3: Quality of Life and Rehabilitation - Prostate cancer treatment should focus not only on extending survival but also on enhancing the quality of life [2] - Post-surgery rehabilitation, particularly pelvic floor muscle training, is crucial for improving urinary incontinence issues [2] - A multidisciplinary approach to managing bone metastasis has shown significant effectiveness in alleviating pain and preventing fractures [2] Group 4: Public Awareness and Prevention - Prostate cancer is transitioning from a high-mortality tumor to a manageable chronic disease through scientific screening and comprehensive management [2] - There is a need for increased public awareness regarding cancer prevention and the importance of proactive screening [2]